References
- Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C., Binet J.L., French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: present status and future directions. Blood 1991; 78, 1901-1914
- Bancherau J., Brière F., Liu Y.J., Rousset F. Molecular control of B lymphocyte growth and differentiation. Stem Cells 1994; 12: 278–88
- Cohen J.J., Duke R.C., Fadok V.A., Sellins K.S. Apoptosis and programmed cell death in immunity. Ann Rev Immunol 1992; 10: 267–93
- Urashima M., Ogata A., Chauhan D., Hatziyanni M., Vidriales M.B., Dedera D.A., Schlossman R.L., Anderson K.C. Transforming growth factor-β1: differential effects on multiple myeloma versus normal B-cells. Blood 1996; 87, 1928-38
- Buske C., Becker D., Feuring-Buske M., Hannig H., Wuef G., Schofer C., Hiddemann W., Wormann B. TGF-β inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia 1997; 11: 386–92
- Kehrl J.H., Roberts A.B., Wakefield L.M., Jakowlew S., Sporn M.B., Fauci A.S. Transforming growth factor β is an important immunomodulatory protein for human B-lymphocytes. J Immunol 1986; 137: 3855–60
- Smeland E.B., Blomhoff H.K., Holte H., Ruud E., Beiske K., Funderud S., Godal T., Ohlsson R. Transforming growth factor β inhibits G1 to S transition but not activation of human B lymphocytes. Exp Cell Res 1997; 171: 213–22
- Lagneaux L., Delforge A., Bron D., Massy M., Bernier M., Stryckmans P. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-β receptors. Br J Haematol 1997; 97: 612–20
- Israels L.G., Israel S.J., Begleiter A., Verbrug L., Schwartz L., Mowat M.R.A., Johnston J.B. Role of transforming growth factor β in chronic lymphocytic leukemia. Leuk Res 1993; 17: 81–7
- Douglas R.S., Capocasale R.J., Lamb R.J., Nowell P.C., Moore J.S. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor β. Blood 1997; 89: 941–7
- Lotz M., Ranheim E., Kipps T.J. Transforming growth factor β as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 1994; 179: 999–1004
- Moore J.S., Capocasale R.J., Fox F.E., Lamb R.J., Besa E.C., Penziner A.S., Nowell P.C. Response of CLL B-cells to transforming growth factor-beta reflects biological heterogeneity. Blood 1993; 82: 573a, abstr
- Laiho M., Weis F., Massagué J. Concomitant loss of transforming growth factor-β receptor type I and type II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J. Biol Chem 1990; 265: 18518–24
- Kumar A., Rogers T., Maizel A., Sharma S. Loss of transforming growth factor beta-1 receptor and its effect on the growth of EBV-transformed human B-cells. J Immunol 1991; 147: 998–1006
- Lin H.Y., Moustakas A. TGF-β receptors: structure and function. Cell Mol Biol 1994; 40: 337–49
- Park K., Kim S.J., Bang Y.J., Park J.G., Kim N.K., Roberts A.B., Sporn M.B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TFG-β. Proc Natl Acad Sci USA 1994; 91: 8772–8776
- Baldwin R.L., Friess H., Yokoyama M., Lopez M.E., Kobrin M.S., Buchler M.W., Korc M. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 1996; 67: 283–8
- Kadin M.E., Cacaille-Coll M.W., Gertz R., Massague J., Cheifetz J., George D. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci 1994; 91: 6002–6
- Lagneaux L., Delforge A., Bron D., Bosmans E., Stryckmans P. Comparative analysis of cytokines released by bone maroow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients. Leuk Lymphoma 1995; 17: 127–33
- Nowell P.C., Moore J.S., Fox F.E., Capocasale R.J., Kant J.A., Besa E.C. Richter's syndrome associated with loss of response to transforming growth factor-beta. Leukemia Res 1994; 18: 85–89
- DeCoteau J.F., Knaus P.I., Yankelev Haya, Reiss M.D., Lowsky R., Lodish H.F., Kadin M.E. Loss of functional surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc Natl Acad Sci 1997; 94: 5877–81
- Moore J.S., Friedman D.F., Silberstein L.E., Besa E.C., Nowell P.C. Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia. Crit Rev Oncol Hematol 1995; 20: 141–64
- Lomo J., Blomhoff H.K., Beiske K., Stokke T., Smeland E.B. TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995; 154: 1634–43
- Ohta S., Yanagihara K., Nagata K. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem J 1997; 324: 777–82
- Chaouchi N., Arvanitakis L., Auffredou M.T., Blanchard D.A., Vazquez A., Sharma S. Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 1995; 11: 1615–22